Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Removal and Margin Ablation for Breast Cancer

NCT00574301 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00574301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Removal and Margin Ablation for Breast Cancer
Lead sponsor
University of Arkansas
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2002
Completion date
October 31, 2011
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer